Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from Medipal Holdings ( (JP:7459) ).
Medipal Holdings’ board has approved a tender offer to acquire all remaining common shares of Paltac Corporation that it does not already own, at a price of ¥6,650 per share, between May 12 and July 7, 2026. The company currently holds 52.40% of Paltac and aims to lift its ownership ratio to 66.67% or more, ultimately making the distributor a wholly owned subsidiary.
The tender offer has the support of Paltac’s board, which is recommending that shareholders tender their shares into the bid. Full ownership is expected to streamline group governance and integration within Medipal’s distribution network, potentially enhancing operational efficiencies and strengthening its position in Japan’s healthcare and consumer goods logistics market.
The most recent analyst rating on (JP:7459) stock is a Hold with a Yen2700.00 price target. To see the full list of analyst forecasts on Medipal Holdings stock, see the JP:7459 Stock Forecast page.
More about Medipal Holdings
Medipal Holdings is a Tokyo-listed wholesaler that operates one of Japan’s largest distribution networks for prescription pharmaceuticals, cosmetics, daily necessities, OTC drugs, animal health products and food processing raw materials. Through a group of 32 subsidiaries and 19 affiliates, it supplies healthcare and consumer goods nationwide, and already consolidates Paltac as a majority-owned subsidiary on the Prime Market.
YTD Price Performance: 1.19%
Average Trading Volume: 412,589
Technical Sentiment Signal: Buy
Current Market Cap: Yen503B
For detailed information about 7459 stock, go to TipRanks’ Stock Analysis page.